U.S. markets closed

Novus Acquisition & Development Corp. (NDEV)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0510-0.0030 (-5.56%)
At close: 3:18PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0540
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0510 - 0.0550
52 Week Range0.0410 - 0.1750
Avg. Volume42,703
Market Cap4.991M
Beta (5Y Monthly)-0.09
PE Ratio (TTM)4.25
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for NDEV

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    UFPI: Raising target price to $78.00UFP INDUSTRIES INC has an Investment Rating of HOLD; a target price of $78.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    13 days agoArgus Research
View more
  • GlobeNewswire

    Novus Reports Second Quarter 2021 Results

    Signs First Oklahoma Provider and Continued Execution of Carrier AgreementsMIAMI, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Novus Acquisition and Development, Corp. (OTC Markets: NDEV), through its wholly-owned subsidiary WCIG Insurance Services, LLC., is a hybrid health insurance entity and, the nation’s first health carrier offering cannabis in health plans to recreational and medicinal users, today reported its second quarter financial results for the three months ended June 30, 2021 and its expansio


    Novus Signs Partnership With PRAM, a Leading Pharmacy Consulting, and Underwriting Firm

    Proud to be Aligned with a Proprietary Prescription Drug Benefits Powerhouse As We Begin Our Roll Out To Their Distribution BaseMIAMI, FL / ACCESSWIRE / July 19, 2021 / Novus Acquisition and Development, Corp. (OTC PINK:NDEV), through its wholly-owned subsidiary WCIG Insurance Services, LLC.


    Novus Reports First Quarter 2021 Results

    Continued Ramping of Prominent Insurance Distributors Leads to GrowthMIAMI, FL / ACCESSWIRE / May 18, 2021 / Novus Acquisition and Development, Corp. (OTC PINK:NDEV), through its wholly-owned subsidiary WCIG Insurance Services, LLC.